doi: 10.1007/s11596-020-2281-2 40 BekdashRA
Healthcare provider networks develop specialized obesity medicine programs integrating pharmacotherapy with comprehensive lifestyle intervention services
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Ethics declarations Funding The authors wish to thank Daniel Soares Freire, MD, PhD for providing medical writing and Cristiane Mapurunga Aoqui Guenoub, MD, PhD for providing assistance with English-language editing, both on behalf of Springer Healthcare
Eating smaller, more frequent meals helps significantly
Jillian was not involved.) Entering Her Purple MAHA Era Over the past two decades, Jillian has had a concerning revelation: The most straightforward health and weight-loss tenet, which she describes as eat less and move more, is no longer hitting for her audience
